|Sildenafil citrate treatment enhances amino acid availability in the conceptus and fetal growth in an ovine model of intrauterine growth restriction.|
|PMID: 20018809 Owner: NLM Status: MEDLINE|
|Adequate placental blood flow is essential for the optimal delivery of nutrients from mother to fetus for conceptus growth. Restricted fetal development results from pathophysiological and environmental factors that alter utero-placental blood flow, placental function, and, therefore, nutrient availability in the fetus. To test this hypothesis, 0, 75, or 150 mg/d sildenafil citrate (Viagra) was administered subcutaneously from d 28 to 115 of gestation to either nutrient-restricted [50% of NRC requirements) or adequately-fed ewes (100% of NRC requirements). On d 115, maternal, fetal, and placental tissues and fluids were collected. Concentrations of total amino acids and polyamines in uterine venous and arterial sera, amniotic and allantoic fluids, and fetal umbilical venous serum were lower (P < 0.05) in nutrient-restricted ewes than in adequately fed ewes, as were the ratios of total amino acids in fetal umbilical venous serum to uterine arterial serum. Sildenafil citrate dose-dependently increased (P < 0.05) total amino acids and polyamines in amniotic fluid, allantoic fluid, and fetal serum without affecting values in maternal serum. Fetal weight was lower (P < 0.05) in nutrient-restricted ewes on d 115. Sildenafil citrate treatment dose-dependently increased (P < 0.05) fetal weight in both nutrient-restricted and adequately fed ewes. This study supports the hypothesis that long-term sildenafil citrate treatment enhances fetal growth, at least in part, by increasing the availability of amino acids in the conceptus. These findings may lead to the clinical use of sildenafil citrate in human pregnancies suspected to be at risk for intrauterine fetal growth retardation.|
|M Carey Satterfield; Fuller W Bazer; Thomas E Spencer; Guoyao Wu|
Related Documents :
|7337399 - Efficacy of a long-acting oxytetracycline against chlamydial ovine abortion.
7130059 - A quantitative study of vascularisation of the prenatal rabbit spinal cord.
469859 - Trophoblastin, an antiluteolytic protein present in early pregnancy in sheep.
10869859 - Metabolic responses to mid-pregnancy shearing that are associated with a selective incr...
8270529 - Influence of the corpus luteum of pregnancy on ovarian function in postpartum ewes.
16737779 - Effect of nutritional status and fat reserves on the periparturient immune response to ...
23845169 - Outcome of pregnancies with preterm prelabor rupture of membranes before 27 weeks' gest...
8408489 - Disturbances of sperm flagella due to failure of epididymal maturation and their possib...
850569 - Maternal mortality due to ectopic pregnancy. a review of 102 deaths.
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-12-16|
|Title: The Journal of nutrition Volume: 140 ISSN: 1541-6100 ISO Abbreviation: J. Nutr. Publication Date: 2010 Feb|
|Created Date: 2010-01-21 Completed Date: 2010-02-04 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 0404243 Medline TA: J Nutr Country: United States|
|Languages: eng Pagination: 251-8 Citation Subset: IM|
|Department of Animal Science, Texas A&M University, College Station, TX 77843-2471, USA.|
|APA/MLA Format Download EndNote Download BibTex|
Amniotic Fluid / metabolism
Animal Nutritional Physiological Phenomena / drug effects
Dietary Proteins / blood
Disease Models, Animal
Dose-Response Relationship, Drug
Embryonic Development / drug effects
Fetal Growth Retardation / blood, prevention & control*
Fetal Weight / drug effects*
Fetus / blood supply, drug effects*, metabolism
Maternal Nutritional Physiological Phenomena
Piperazines / administration & dosage, pharmacology, therapeutic use*
Placenta / blood supply, drug effects
Polyamines / blood
Prenatal Nutritional Physiological Phenomena / drug effects*
Purines / administration & dosage, pharmacology, therapeutic use
Sulfones / administration & dosage, pharmacology, therapeutic use*
Umbilical Veins / metabolism
Uterine Artery / metabolism
Vasodilator Agents / administration & dosage, pharmacology, therapeutic use*
|0/Amino Acids; 0/Dietary Proteins; 0/Piperazines; 0/Polyamines; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 139755-83-2/sildenafil|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Age and Dietary Iron Affect Expression of Genes Involved in Iron Acquisition and Homeostasis in Youn...
Next Document: Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide ex...